Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- ChecktodayChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal HTML, replacing the former study record content and navigation. This means the NCT05980949 study details are no longer accessible from this URL.SummaryDifference21%

- Check35 days agoChange DetectedThe UI text for finding contact information changed capitalization from 'Find Contact Information' to 'Find contact information'. The page revision updated from v3.6.6 to v3.7.0.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now includes a 2023 U.S. NIH grant/contract funding note. It also updates the revision version to v3.6.6, from v3.6.5, indicating updated metadata and documentation.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.